S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

MYGN Myriad Genetics Inc

23.20

-0.09 (-0.39%)

Jun 14 2024 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Myriad Genetics (NASDAQ:MYGN)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Myriad Genetics Charts.

Myriad Genetics (NASDAQ:MYGN)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Myriad Genetics Charts.

Myriad Genetics Inc News

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries
Tuesday 11 June 2024 (6 days ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 10 June 2024 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 June 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 June 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 June 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 June 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 June 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 June 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 June 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 6 June 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 June 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 4 June 2024 (2 weeks ago) • Edgar (US Regulatory)

More Myriad Genetics Inc News Articles

Voyageur Pharmaceuticals (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions